These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26766)

  • 21. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific stimulating effect of glycine on 3H-dopamine efflux from substantia nigra slices of the rat.
    Kerwin RW; Pycock CJ
    Eur J Pharmacol; 1979 Feb; 54(1-2):93-8. PubMed ID: 421746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo biosynthesis of [35S]- and [3H]substance P in the striatum of the rat and their axonal transport to the substantia nigra.
    Krause JE; Reiner AJ; Advis JP; McKelvy JF
    J Neurosci; 1984 Mar; 4(3):775-85. PubMed ID: 6200582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple opiate receptors may be involved in suppressing gamma-aminobutyrate release in substantia nigra.
    Starr MS
    Life Sci; 1985 Dec; 37(24):2249-55. PubMed ID: 2999545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase.
    Stoof JC; Mulder AH
    Eur J Pharmacol; 1977 Nov; 46(2):177-80. PubMed ID: 590329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of substance P injected into the substantia nigra.
    James TA; Starr MS
    Br J Pharmacol; 1979 Mar; 65(3):423-9. PubMed ID: 427315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory effect of substance P on the spontaneous release of newly synthesized [3H]dopamine from rat striatal slices: a tetrodotoxin-sensitive process.
    Petit F; Glowinski J
    Neuropharmacology; 1986 Sep; 25(9):1015-21. PubMed ID: 2430228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of opioid drugs on the release of dopamine and 5-hydroxytryptamine from rat striatum following activation of nicotinic-cholinergic receptors.
    Westfall TC; Grant H; Naes L; Meldrum M
    Eur J Pharmacol; 1983 Aug; 92(1-2):35-42. PubMed ID: 6628536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
    Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
    Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
    J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of GABA-mediated inhibition of the electrically and potassium chloride evoked [3H]-GABA release from rat substantia nigra slices by DL-3-hydroxy-3-phenyl pentanamide.
    Meza-Toledo SE; Bowery NG
    Arzneimittelforschung; 2008; 58(2):53-61. PubMed ID: 18412018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of GABA, L-glutamic acid and nicotine on the potassium-evoked release of substance P in substantia nigra slices of the rat.
    Torrens Y; Beaujouan JC; Besson MJ; Michelot R; Glowinski J
    Eur J Pharmacol; 1981 May; 71(4):383-92. PubMed ID: 6166487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.
    Zhou FC; Bledsoe S; Murphy J
    Brain Res; 1991 Aug; 556(1):108-16. PubMed ID: 1718555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism.
    Humpel C; Saria A; Regoli D
    Eur J Pharmacol; 1991 Mar; 195(1):107-14. PubMed ID: 1712305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo release of transmitters in the cat basal ganglia.
    Glowinski J
    Fed Proc; 1981 Feb; 40(2):135-41. PubMed ID: 6161843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists.
    Moroni F; Peralta E; Cheney DL; Costa E
    J Pharmacol Exp Ther; 1979 Feb; 208(2):190-4. PubMed ID: 762651
    [No Abstract]   [Full Text] [Related]  

  • 40. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
    Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
    Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.